Clever Leaves Holdings Inc. (CLVR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 720 Thousand USD | -66.54% |
| 2022 | 2.15 Million USD | -71.64% |
| 2021 | 7.58 Million USD | -77.58% |
| 2020 | 33.84 Million USD | 0.34% |
| 2019 | 33.72 Million USD | 137.37% |
| 2018 | 14.2 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q1 | 1.63 Million USD | -23.84% |
| 2023 FY | 720 Thousand USD | -66.54% |
| 2023 Q2 | 1.29 Million USD | -20.87% |
| 2023 Q3 | 1.22 Million USD | -5.55% |
| 2023 Q4 | 720 Thousand USD | -41.22% |
| 2022 FY | 2.15 Million USD | -71.64% |
| 2022 Q4 | 2.15 Million USD | -26.33% |
| 2022 Q3 | 2.92 Million USD | -15.77% |
| 2022 Q2 | 3.46 Million USD | -58.79% |
| 2022 Q1 | 8.41 Million USD | 10.93% |
| 2021 Q2 | 6.55 Million USD | -81.36% |
| 2021 Q1 | 35.19 Million USD | 3.98% |
| 2021 FY | 7.58 Million USD | -77.58% |
| 2021 Q4 | 7.58 Million USD | -41.98% |
| 2021 Q3 | 13.07 Million USD | 99.37% |
| 2020 Q4 | 33.84 Million USD | -13.54% |
| 2020 FY | 33.84 Million USD | 0.34% |
| 2020 Q3 | 39.14 Million USD | 13.32% |
| 2020 Q2 | 34.54 Million USD | 1.46% |
| 2020 Q1 | 34.04 Million USD | 0.94% |
| 2019 Q4 | 33.72 Million USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 33.72 Million USD | 137.37% |
| 2018 FY | 14.2 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 99.767% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | 99.209% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 99.853% |
| Cosmos Health Inc. | 3.03 Million USD | 76.279% |
| Dynavax Technologies Corporation | 252.41 Million USD | 99.715% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | 94.597% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 99.86% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -33.572% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -33.572% |
| SCYNEXIS, Inc. | 12.15 Million USD | 94.078% |
| Safety Shot Inc | 304.9 Thousand USD | -136.138% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -514.707% |
| Alpha Teknova, Inc. | 13.25 Million USD | 94.566% |
| Bright Green Corporation | 201.78 Thousand USD | -256.819% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 99.856% |
| Embecta Corp. | 1.62 Billion USD | 99.956% |
| PainReform Ltd. | 30 Thousand USD | -2300.0% |
| Journey Medical Corporation | 14.62 Million USD | 95.076% |
| Procaps Group, S.A. | 28.41 Million USD | 97.466% |
| Theratechnologies Inc. | 51.26 Million USD | 98.595% |
| Harrow Health, Inc. | 183.17 Million USD | 99.607% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -727.586% |
| Biofrontera Inc. | 804 Thousand USD | 10.448% |
| DURECT Corporation | 2.7 Million USD | 73.353% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | 97.831% |
| Cronos Group Inc. | 1.55 Million USD | 53.817% |
| OptiNose, Inc. | 611 Thousand USD | -17.84% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 99.856% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | 97.894% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -58.242% |
| Organogenesis Holdings Inc. | 60.74 Million USD | 98.815% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | 94.368% |
| Radius Health, Inc. | 339.66 Million USD | 99.788% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | 92.981% |
| Phibro Animal Health Corporation | 458.28 Million USD | 99.843% |
| Procaps Group S.A. | 28.41 Million USD | 97.466% |
| Alvotech | 1.02 Billion USD | 99.93% |
| TherapeuticsMD, Inc. | 6.53 Million USD | 88.977% |
| Viatris Inc. | 16.18 Billion USD | 99.996% |
| Rockwell Medical, Inc. | 8.29 Million USD | 91.318% |
| Aytu BioPharma, Inc. | 10.87 Million USD | 93.381% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -114.291% |
| Tilray Brands, Inc. | 287.93 Million USD | 99.75% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | 99.403% |
| Shineco, Inc. | 10.01 Million USD | 92.812% |
| PetIQ, Inc. | 437.82 Million USD | 99.836% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | -242.857% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 99.721% |
| Alimera Sciences, Inc. | 64.48 Million USD | 98.884% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | 98.131% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -432.982% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | 89.5% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -3102.277% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | 97.802% |
| Hempacco Co., Inc. | 5.93 Million USD | 87.86% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | 99.93% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 98.719% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 99.883% |
| Currenc Group, Inc. | 2.5 Million USD | 71.28% |
| Kamada Ltd. | 7.43 Million USD | 90.32% |
| Indivior PLC | 235.66 Million USD | 99.694% |
| Evoke Pharma, Inc. | 5 Million USD | 85.6% |
| Flora Growth Corp. | 942 Thousand USD | 23.567% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -3102.277% |
| Evolus, Inc. | 120.35 Million USD | 99.402% |
| HUTCHMED (China) Limited | 48.18 Million USD | 98.506% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 99.878% |
| Akanda Corp. | 2.49 Million USD | 71.167% |